Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT

Key facts

Sponsor

Sunnybrook Health Sciences Centre

Principal Investigator

William Chu, MD, FRCPC

Sunnybrook Health Sciences Center

Intervention

Stereotactic body radiotherapy(radiation)

Enrollment

70 enrolled

Eligibility

18 years · All sexes

Timeline

2022 – 2026

Study locations (1)

• Sunnybrook Health Sciences, Toronto, Ontario, Canada

Collaborators

Juravinski Cancer Center · Health Sciences North · Grand River Regional Cancer Centre · British Columbia Cancer Agency · London Health Sciences Centre · Durham Regional Cancer Centre

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Hereditary clear cell renal cell carcinoma

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1, PHASE2NCT07293351
  A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
  Bristol-Myers Squibb
• RECRUITINGPHASE1NCT07401875
  A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
  M.D. Anderson Cancer Center
• RECRUITINGPHASE2NCT07489534
  Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction
  Daihong Liu
• ENROLLING BY INVITATIONNANCT06945640
  Evaluation of 'RUS NE' in Robot-Assisted Partial Nephrectomy: Efficacy, Safety, and Stability
  Hutom Corp
• RECRUITINGPHASE2NCT07229040
  A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin.
  Hospital General Universitario Gregorio Marañon
• RECRUITINGNANCT07367750
  Testing the Feasibility of a Self-Management Support Program for Patient With Chronic Diseases in Israel
  University of Haifa
• RECRUITINGNCT07303725
  Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
  Palo Alto Veterans Institute for Research
• RECRUITINGPHASE1NCT06623630
  Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
  Washington University School of Medicine

See all trials for Hereditary clear cell renal cell carcinoma →